Enzium

About:

Enzium develops fluorescent based reagents for selective protease.

Website: http://enziumlabs.com

Top Investors: BioAdvance

Description:

Enzium is dedicated to developing fluorescent based reagents for highly selective protease activity detection using their proprietary modular protein and dye technology. Their technology allows us to quickly swap out protein modules, much like legos, to easily build new, selective assay reagents. It is their goal to enable their customers to integrate the same reagent kit/assay in applications across entire research, drug, and diagnostic development pipelines.

Total Funding Amount:

$750000

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Philadelphia, Pennsylvania, United States

Founded Date:

2011-01-01

Contact Email:

info(AT)enziumlabs.com

Founders:

Crystal Falco, Edan Yago, Peter Berget

Number of Employees:

1-10

Last Funding Date:

2016-07-06

IPO Status:

Private

Industries:

© 2025 bioDAO.ai